TwoStepTx

Our co-founder and CEO @CaitlynBioE spoke with @ky_lahucik about our work developing a novel tumor-targeting platform for solid tumors - and how this approach opens up new possibilities for cancer treatment. Read more in @endpts News👇 endpts.com/new-cancer-bio…

My dad died from colon cancer in 2020, NFX bio principal Gita Bassman Reinitz lots two parents to cancer, so many people we know are effected by this horrible disease.. businesswire.com/news/home/2024…

1/ We’re excited to announce our official launch and the closing of a $6.5M seed round to advance our pipeline of targeted therapies for solid tumors. Learn more 👉 businesswire.com/news/home/2024…

We are thrilled to announce our latest investment in @TwoStepTx! Read more about why we invested 👇 2048.vc/blog/our-inves… 💡 Enabling targeted delivery to virtually any solid tumor using a unique and modular polyspecific integrin-binding peptide. 👩‍💻 The Founder: @CaitlynBioE 📌 Location: San Francisco, CA 💰 Investment Stage: Seed You can also read more in this article (shoutout to @ky_lahucik for the writeup!) endpts.com/new-cancer-bio…

congrats @CaitlynBioE and @TwoStepTx on the launch! endpts.com/new-cancer-bio…

Thrilled to share that @TwoStepTx has officially launched! With the closing of our seed round, we’ll be advancing our pipeline of targeted therapies for solid tumors. Many thanks to our incredible co-founders and investors for their support. @CarolynBertozzi @CochranLab

5/ We launched from @Stanford Innovative Medicines Accelerator and are backed by investors led by @NFX with participation from @2048vc, Alexandria Venture Investments, @CooleyLLP affiliated fund GC&H Investments, and the family office of the founder of Arcadia Investment Partners

4/ Our work is guided by world-class academic-entrepreneurs at Stanford, including co-founders @CarolynBertozzi , Jennifer Cochran @CochranLab and Ron Levy.